SCHEMBL22939775

SCHEMBL22939775

CC(=O)n1nc(C(=O)Nc2ccc(F)cc2Cl)c(Cl)c1Cl

nearest known ligand 0.57

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 13/20 0.57
LMNA P02545 2/20 0.50
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
GRM4 Q14833 1/20 0.42
RIPK1 Q13546 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22939773 0.90 LMNA (0.56) ALOX15LMNAMAPT
SCHEMBL22939286 0.90 ALOX15 (0.57) ALOX15LMNAMAPTNPSR1RIPK1
SCHEMBL25959700 0.88 ALOX15 (0.64) ALOX15LMNAMAPTNPSR1
SCHEMBL22939774 0.88 NPC1 (0.46) ALOX15MAPTNPSR1
SCHEMBL25958289 0.86 POLB (0.50) LMNAMAPT
SCHEMBL22939356 0.83 ALOX15 (0.64) ALOX15LMNAMAPTNPSR1
SCHEMBL22257173 0.83 ALOX15 (0.50) ALOX15LMNAMAPT
SCHEMBL22256805 0.83 ALOX15 (0.47) ALOX15LMNAMAPT
SCHEMBL25958292 0.82 LMNA (0.44) LMNAMAPTRIPK1
SCHEMBL22257202 0.81 ALOX15 (0.55) ALOX15LMNANPSR1GRM4RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME EMPIRICO INC. 2023-08-10 US disclosed
US-11666588-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same EMPIRICO INC. (US) 2023-06-06 US disclosed
US-11116778-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same EMPIRICO INC. (US) 2021-09-14 US disclosed
US-20210030772-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME EMPIRICO INC. 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME ALOX15, ALOX5, ALOX15B ALOX15 1/4885LMNA 2806/4885MAPT 3361/4885
US-20210030772-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME ALOX15, ALOX5, ALOX15B ALOX15 1/4885LMNA 2806/4885MAPT 3361/4885
US-11666588-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same ALOX15, ALOX5, ALOX15B ALOX15 1/4885LMNA 2806/4885MAPT 3361/4885
US-11116778-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same ALOX15, ALOX5, ALOX15B ALOX15 1/4885LMNA 2806/4885MAPT 3361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.